# Optimized Medico-pharmaceutical Collaboration in the Drug Management of Patients With Heart Failure

> **NCT03902028** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 229 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **OTHER:** Reinforced multidisciplinary follow-up

## Key facts

- **NCT ID:** NCT03902028
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-02
- **Primary completion:** 2025-01-25
- **Final completion:** 2025-01-25
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03902028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03902028, "Optimized Medico-pharmaceutical Collaboration in the Drug Management of Patients With Heart Failure". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03902028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*